Skip to main content

Table 4 Anemia and its associated factor after HAART initiation in HIV patients at University of Gondar hospital, North West Ethiopia from 2008-2013

From: Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study

Variables

Anemic

Non-anemic

X2

P value

Sex

Male

10(7.6%)

121(92.4%)

3.028

0.082

Female

30(13.8%)

188(86.2)

Age

<25 years

6(13%)

40(87%)

1.336

0.721

26-35 years

18(11.7%)

136(88.3%)

36-45 years

14(12.3%)

100(87.7%)

>46 years

2(5.7%)

33(94.3%)

Regimen type

AZT based

24(11.2%)

191(88.8%)

0.049

0.825

Non AZT based

16(11.9%)

118(88.1%)

Cotrimoxazole

Yes

35(11.4%)

271(88.6%)

0.001

0.971

No

5(11.6%)

38(88.4%)

CD4 cells//μl

<200

18(18%)

82(82%)

5.953

0.051

200-350

12(8.5%)

130(91.5%)

 

>350

10(9.3%)

97(90.7%)